These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20204336)

  • 1. Warfarin-flucloxacillin interaction presenting as cardioembolic ischemic stroke.
    Merwick A; Hannon N; Kelly PJ; O'Rourke K
    Eur J Clin Pharmacol; 2010 Jun; 66(6):643-4. PubMed ID: 20204336
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 3. Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin.
    Hellfritzsch M; Lund LC; Ennis Z; Stage T; Damkier P; Bliddal M; Jensen PB; Henriksen D; Ernst MT; Olesen M; Broe A; Kristensen KB; Hallas J; Pottegård A
    Clin Pharmacol Ther; 2020 Mar; 107(3):607-616. PubMed ID: 31563140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous flucloxacillin may affect warfarin therapy.
    Choi PY; Phillips KL; Rae I
    Med J Aust; 2011 Jun; 194(11):613. PubMed ID: 21644882
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients with atrial fibrillation often receive improper levels of warfarin.
    Mitka M
    JAMA; 2008 Oct; 300(14):1640. PubMed ID: 18840828
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustainability and impact of warfarin compliance for atrial fibrillation.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828
    [No Abstract]   [Full Text] [Related]  

  • 7. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 12. Warfarin for stroke prevention in atrial fibrillation: time to switch?
    Ahmad Y; Lip GY
    Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
    [No Abstract]   [Full Text] [Related]  

  • 13. Atrial fibrillation and stroke prevention.
    Hart RG
    N Engl J Med; 2003 Sep; 349(11):1015-6. PubMed ID: 12968083
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation: a pathway to clinical effectiveness.
    Barnes GD; Froehlich JB
    Am J Med; 2009 Feb; 122(2):126-8. PubMed ID: 19185085
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AParadigm Shift: The New Novel Oral Anticoagulation Agents.
    Saeed W; Burke JF; Mirrani G; Sirinivasa M; Nabi U; Hayat U; Khan Z; Sardar MR
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):611-9. PubMed ID: 27504556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flucloxacillin-warfarin interaction: an under-appreciated phenomenon.
    Chaudhuri A; Wade SL
    Intern Med J; 2018 Jul; 48(7):860-863. PubMed ID: 29984514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
    Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S;
    BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
    Lane DA; Lip GY
    Thromb Haemost; 2010 Feb; 103(2):254-6. PubMed ID: 20076858
    [No Abstract]   [Full Text] [Related]  

  • 20. Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Nunan D; Heneghan C
    Heart; 2015 Nov; 101(21):1689-90. PubMed ID: 26135804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.